Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Cell

• Publication date

  2017-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2017.06.001PMID 28697340PMCID PMC5552197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis

  2016cited by this paper
• Anaplastic lymphoma kinase inhibitors

  2015cited by this paper
• Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas

  2015cited by this paper
• MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis

  2015cited by this paper
• Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance

  2014cited by this paper
• CRISPR-mediated direct mutation of cancer genes in the mouse liver

  2014cited by this paper
• A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

  2014cited by this paper
• Chimeric antigen receptor therapy for cancer.

  2014cited by this paper
• MYC degradation.

  2014cited by this paper
• CaMKII inhibitors: from research tools to therapeutic agents

  2014cited by this paper
• Translational Medicine in Action: Anti-CD20 Therapy in Lymphoma

  2014cited by this paper
• Genome engineering using the CRISPR-Cas9 system

  2013cited by this paper
• Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis

  2013cited by this paper
• Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II

  2013cited by this paper
• CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine.

  2012cited by this paper
• Functional genomics identifies therapeutic targets for MYC-driven cancer

  2012cited by this paper
• Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells

  2012cited by this paper
• MYC on the path to cancer.

  2012cited by this paper
• Molecular Profiling of Aggressive Lymphomas

  2011cited by this paper
• Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.

  2011cited by this paper
• Proteolytic control of the oncoprotein transcription factor Myc.

  2011cited by this paper
• Reviewing once more the c-myc and Ras collaboration

  2011cited by this paper
• Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression

  2011cited by this paper
• MYC as a regulator of ribosome biogenesis and protein synthesis

  2010cited by this paper
• Berbamine derivatives: a novel class of compounds for anti-leukemia activity.

  2009cited by this paper
• The γ isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption

  2009cited by this paper
• Crosstalk between c‐Myc and ribosome in ribosomal biogenesis and cancer

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.

  2008cited by this paper
• Transcription-independent functions of MYC: regulation of translation and DNA replication

  2008cited by this paper
• Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

  2007cited by this paper
• Physiological roles of the Ca2+/CaM-dependent protein kinase cascade in health and disease.

  2007cited by this paper
• Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

  2007cited by this paper
• Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

  2006cited by this paper
• Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias

  2006cited by this paper
• A Pivotal Role for the Multifunctional Calcium/Calmodulin-Dependent Protein Kinase II in T Cells: From Activation to Unresponsiveness1

  2005cited by this paper
• Ubiquitin Ligases in Malignant Lymphoma

  2004cited by this paper
• [Study on effect of berbamine on multidrug resistance leukemia K562/Adr cells].

  2004cited by this paper
• Myc pathways provoking cell suicide and cancer

  2003cited by this paper
• Calcium: Regulation of cell death: the calcium–apoptosis link

  2003cited by this paper
• Intracellular calcium signaling

  2002cited by this paper
• Ca(2+)/CaM-dependent kinases: from activation to function.

  2001cited by this paper
• A role for CaMKII in T cell memory.

  2000cited by this paper
• Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

  2000cited by this paper
• Ras enhances Myc protein stability.

  1999cited by this paper
• Mechanisms of apoptosis by c-Myc

  1999cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• Substrate-directed Function of Calmodulin in Autophosphorylation of Ca2+/Calmodulin-dependent Protein Kinase II*

  1998cited by this paper
• Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain

  1998cited by this paper
• Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.

  1994cited by this paper
• The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase.

  1993cited by this paper
• The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells.

  1991cited by this paper
• The myc oncogene: its role in transformation and differentiation.

  1986cited by this paper
• Gross and microscopic changes in the lymphoreticular system during genesis of malignant lymphoma induced by a single injection of methylnitrosourea in adult mice.

  1970cited by this paper

• Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription

  2025cites this paper
• Nuclear CaMKII Isoforms as Regulators of Transcription: From Developmental to Pathological Persistence

  2025cites this paper
• Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma

  2025cites this paper
• Multifunctional hydrogels for synergistic therapy of cutaneous melanoma-associated tumor recurrence and wound regeneration

  2025cites this paper
• TRIM24 promotes T-cell lymphoma development and glucocorticoid resistance via FUS-mediated phase separation of the glucocorticoid receptor.

  2025cites this paper
• SERCA-mediated endoplasmic reticulum stress facilitates hematopoietic stem cell mobilization

  2025cites this paper
• Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy.

  2025cites this paper
• Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS

  2025cites this paper
• CAMKIIδ Reinforces Lipid Metabolism and Promotes the Development of B Cell Lymphoma

  2025cites this paper
• Antimicrobial peptide-modified AIE visual composite wound dressing for promoting rapid healing of infected wounds

  2024cites this paper
• Ubiquitination in the T Cell Metabolism-Based Immunotherapy in Diseases.

  2024cites this paper
• The Selective SIRT3 Inhibitor 3-TYP Represses Primary Myeloma Growth by Reducing c-Myc Stability.

  2024cites this paper
• Activation of the Wnt/β-catenin signaling pathway and CTNNB1 mutations in canine intestinal epithelial proliferative lesions

  2024cites this paper
• STK16 promoted colorectal cancer progress in a c-MYC signaling-dependent manner

  2024cites this paper
• Manipulating Myc for reparative regeneration

  2024cites this paper
• Inhibition of NFAT5‐Dependent Astrocyte Swelling Alleviates Neuropathic Pain

  2024cites this paper
• Demystifying the Druggability of the MYC Family of Oncogenes.

  2023cites this paper
• Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish

  2023cites this paper
• Pharmacological profiling of a berbamine derivative for lymphoma treatment

  2023cites this paper
• Phosphorylated Hsp27 promotes adriamycin resistance in breast cancer cells through regulating dual phosphorylation of c-Myc.

  2023cites this paper
• Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma

  2023cites this paper
• New frontiers in the design and discovery of therapeutics that target calcium ion signaling: a novel approach in the fight against cancer

  2023cites this paper
• Energy metabolism: a new target for gastric cancer treatment

  2023cites this paper
• The splicing factor proline and glutamine rich promotes the growth of osteosarcoma via the c-Myc signaling pathway.

  2023cites this paper
• Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection

  2023cites this paper
• Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis

  2023cites this paper
• Evolving strategies and application of proteins and peptide therapeutics in cancer treatment.

  2023cites this paper
• DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC

  2023cites this paper
• Strategies to target the cancer driver MYC in tumor cells

  2023cites this paper
• Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry

  2023cites this paper
• Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential

  2022cites this paper
• Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway

  2022cites this paper
• Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway

  2022cites this paper
• ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer

  2022cites this paper
• A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors

  2022cites this paper
• EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis

  2022cites this paper
• Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma

  2022cites this paper
• Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers

  2022cites this paper
• Stabilization of Notch1 and β-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasis

  2022cites this paper
• Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma

  2022influential citation
• Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability

  2022cites this paper
• Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines

  2022cites this paper
• Inhibition of the TPL2-MKK1/2-ERK1/2 pathway has cytostatic effect on B-Cell Lymphoma

  2022cites this paper
• Targeting “undruggable” c-Myc protein by synthetic lethality

  2021cites this paper
• Docosahexaenoic Acid Inhibits Cell Proliferation through a Suppression of c-Myc Protein in Pancreatic Ductal Adenocarcinoma Cells

  2021cites this paper
• LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation

  2021cites this paper
• CAMK2G is identified as a novel therapeutic target for myelofibrosis

  2021cites this paper
• Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR)

  2021cites this paper
• The dysregulated expression and functional effect of CaMK2 in cancer

  2021cites this paper
• Targeting Na+/K+‐ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma

  2021cites this paper
• Ca2+/calmodulin-dependent Protein Kinases in Leukemia Development

  2021cites this paper
• Autophagy-Dependent Apoptosis Induced by Apoferritin-Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells.

  2021cites this paper
• Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway

  2021influential citation
• The Transcriptional Coactivator, ALL1‐Fused Gene From Chromosome 9, Simultaneously Sustains Hypoxia Tolerance and Metabolic Advantages in Liver Cancer

  2021cites this paper
• HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2

  2021cites this paper
• Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis

  2021cites this paper
• Alternative approaches to target Myc for cancer treatment

  2021cites this paper
• Destruction of a Microtubule-Bound MYC Reservoir during Mitosis Contributes to Vincristine's Anticancer Activity

  2020cites this paper
• Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer

  2020cites this paper
• Linalool inhibits the growth of human T cell acute lymphoblastic leukemia cells with involvement of the MAPK signaling pathway

  2020cites this paper
• 苦参碱对NK/T细胞淋巴瘤细胞的增殖抑制作用

  2020cites this paper
• CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis

  2020cites this paper
• Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway

  2020cites this paper
• Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma

  2020cites this paper
• [Proliferation inhibition effects of matrine on natural killer/T-cell lymphoma cells mediated by c-Myc signaling pathway].

  2020cites this paper
• Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel

  2020cites this paper
• The role of aurora A and polo-like kinases in high-risk lymphomas.

  2019cites this paper
• A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression

  2019cites this paper
• Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells.

  2019cites this paper
• The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention

  2019influential citation
• Magnetic‐silk/polyethyleneimine core‐shell nanoparticles for targeted gene delivery into human breast cancer cells

  2019cites this paper
• Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor‐CaMK II‐c‐Myc pathway

  2019cites this paper
• Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca2+

  2019cites this paper
• Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets.

  2019cites this paper
• Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia.

  2019cites this paper
• Association of transcriptional levels of folate-mediated one-carbon metabolism-related genes in cancer cell lines with drug treatment response.

  2019cites this paper
• Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.

  2019cites this paper
• The PHLPP2 phosphatase is a druggable driver of prostate cancer progression

  2019influential citation
• A temporal examination of calcium signaling in cancer- from tumorigenesis, to immune evasion, and metastasis

  2018cites this paper
• Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells

  2018cites this paper
• Targeting an “undruggable” protein

  2017cites this paper
• Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling

  2017cites this paper